文献速递角膜与眼表疾病

柚皮素滴眼液通过抗炎和抗氧化机制抑制角膜新生血管

Naringenin Eye Drops Inhibit Corneal Neovascularization by Anti-Inflammatory and Antioxidant Mechanisms.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2017-01-01

该研究在小鼠碱烧伤诱导的角膜新生血管模型中,评估柚皮素滴眼液(0.08-80 μg;8 μL 的 0.01-10 g/L 溶液)每日两次给药的效果。结果显示柚皮素滴眼液抑制中性粒细胞和巨噬细胞募集、减少角膜上皮厚度下降和新生血管,并抑制炎性细胞因子产生及促血管生成因子表达,同时增强抗氧化能力。结论提示柚皮素滴眼液通过抑制白细胞募集、促血管生成因子表达、炎性细胞因子产生和抗氧化防御丧失,对碱烧伤角膜发挥保护作用。

要点

  • 柚皮素滴眼液抑制碱烧伤诱导的角膜中性粒细胞和巨噬细胞募集。
  • 柚皮素滴眼液减少角膜上皮厚度下降和角膜新生血管。
  • 柚皮素滴眼液抑制IL-1β、IL-6产生及Vegf、Pdgf、Mmp14 mRNA表达。

核心结论

  • 柚皮素滴眼液通过抑制白细胞募集、促血管生成因子表达、炎性细胞因子产生和抗氧化防御丧失,对碱烧伤角膜发挥保护作用。

研究设计与样本

  • 研究为小鼠模型实验:雄性Swiss小鼠右眼角膜碱烧伤(1 N NaOH)诱导新生血管。
  • 柚皮素滴眼液(0.08-80 μg;8 μL 的 0.01-10 g/L 溶液)或赋形剂(生理盐水)从诱导前2天开始,每日两次给药,至动物安乐死。
  • 检测时间点:碱刺激后2、4、6小时测细胞因子和抗氧化能力;3和/或7天测角膜上皮厚度、新生血管、中性粒细胞和巨噬细胞募集及Vegf、Pdgf、Mmp14、Pedf mRNA表达。

主要发现

  • 柚皮素滴眼液抑制碱烧伤诱导的中性粒细胞(髓过氧化物酶活性和Lysm-GFP+细胞募集)和巨噬细胞(N-乙酰-β-D-氨基葡萄糖苷酶活性)向眼内募集。
  • 柚皮素滴眼液减少碱烧伤诱导的角膜上皮厚度下降和角膜新生血管。
  • 柚皮素抑制碱烧伤诱导的细胞因子(IL-1β和IL-6)产生、Vegf、Pdgf和Mmp14 mRNA表达。
  • 柚皮素抑制铁还原抗氧化能力和氮杂双(3-乙基苯并噻唑啉-6-磺酸)自由基清除能力的降低,并增加还原型谷胱甘肽和蛋白结合巯基水平。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the effect of naringenin eye drops in corneal neovascularization induced by alkali (1 N NaOH) burn in mice. METHODS: Corneal neovascularization in the right eye of male Swiss mice was induced by alkali. Treatment with naringenin eye drops (0.08-80 μg; 8 μL of 0.01-10 g/L solution) or vehicle (saline) started 2 days before corneal neovascularization was induced and was performed twice a day. Mice were treated up until the time animals were euthanized and cornea tissue was collected for testing, which was 2, 4, and 6 hours after alkali stimulus for cytokine and antioxidant capacity measurements, and 3 and/or 7 days after alkali stimulus for the assessment of corneal epithelial thickness and neovascularization, neutrophil, and macrophage recruitment, and vascular endothelial growth factor (Vegf), platelet-derived growth factor (Pdgf), matrix metalloproteinase-14 (Mmp14), and pigment epithelium-derived factor (Pedf) mRNA expression. RESULTS: Naringenin eye drops inhibited alkali burn-induced neutrophil (myeloperoxidase activity and recruitment of Lysm-GFP+ cells) and macrophage (N-acetyl-β-D glucosaminidase activity) recruitment into the eye, decrease in epithelial thickness, and neovascularization in the cornea. Further, naringenin inhibited alkali-induced cytokine (IL-1β and IL-6) production, Vegf, Pdgf, and Mmp14 mRNA expression, and the reduction of ferric reducing antioxidant power and Azinobis-(3-Ethylbenzothiazoline 6-Sulfonic acid) radical scavenging capacity as well as increased the reduced glutathione and protein-bound sulfhydryl groups levels. CONCLUSIONS: Collectively, these results indicate that naringenin eye drops are protective in alkali-induced corneal burn by inhibiting leukocyte recruitment, the proangiogenic factor expression, inflammatory cytokine production, and loss of antioxidant defenses.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Oguido APMT, Hohmann MSN, Pinho-Ribeiro FA, et al. Naringenin Eye Drops Inhibit Corneal Neovascularization by Anti-Inflammatory and Antioxidant Mechanisms. Invest Ophthalmol Vis Sci. 2017. PMID: 29117277. doi:10.1167/iovs.16-19702

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。